Indra Mikelsone

Dr. Indra Mikelsone

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 September 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
APAelita Plinta
Aelita Plinta
Peteris TretjakovsPeteris Tretjakovs
Peteris Tretjakovs
SSSimons Svirskis
Simons Svirskis
ILInara Logina
Inara Logina
GGGita Gersone
Gita Gersone
GBGuntis Bahs
Guntis Bahs
The aim of the study was to clarify correlations between body mass index (BMI), blood pressure (BP), and serum levels of cytokines in female migraine patients. A total of 14 migraineurs with aura, and 12 without aura during their interictal period were compared with 25 controls. Interleukin-8 (IL-8), soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1), matrix metalloproteinase-9 (MMP-9), interferon gamma (IFN-γ), monocyte chemoattractant protein-1 (MCP-1), transforming growth factor alpha (TGF-α), and plasminogen activator inhibitor-1 (PAI-1) were measured. Migraineurs have elevated levels of IL-8, but decreased serum levels of PAI-1 and sICAM-1 during the interictal period, regardless of aura. BMI correlates with BP, and also with IFN-γ and MMP-9 only in patients with aura. There are three correlations in migraine patients with aura that are absent in patients without aura: between IL-8 and PAI-1; MMP-9 and IL-8; and IL-8 and sICAM-1. Migraineurs without aura, on the other hand, have correlations that patients with aura do not have (between PAI-1 and MCP-1, sICAM-1; between MMP-9 and sICAM-1, MCP-1; between TGF-α and PAI-1, MMP-9, sICAM-1; between sICAM-1 and MMP-9, PAI-1, MCP-1; as well as between sVCAM-1 and MCP-1). PAI-1, TGF, and MMP-9 could be used as biomarkers to distinguish migraineurs from healthy individuals.

16 July 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
ZSZane Simsone
Zane Simsone
TFTālivaldis Feivalds
Tālivaldis Feivalds
LHLīga Harju
Līga Harju
IMIndra Mikelsone
Indra Mikelsone
IBIlze Blāķe
Ilze Blāķe
TFTalivaldis Freivalds
Talivaldis Freivalds
Biomarkers, including proteins, nucleic acids, antibodies, and peptides, are essential for identifying diseases such as cancer and differentiating between healthy and abnormal cells in patients. To date, studies have shown that cancer stem cells have DNA repair mechanisms that deter the effects of medicinal treatment. Experiments with cell cultures and chemotherapy treatments of these cultures have revealed the presence of small cells, with a small amount of cytoplasm that can be intensively stained with azure eosin, called microcells. Microcells develop during sporosis from a damaged tumor macrocell. After anticancer therapy in tumor cells, a defective macrocell may produce one or more microcells. This study aims to characterize microcell morphology in melanoma cell lines. In this investigation, we characterized the population of cancer cell microcells after applying paclitaxel treatment to a Sk-Mel-28 melanoma cell line using immunocytochemical cell marker detection and fluorescent microscopy. Paclitaxel-treated cancer cells show stronger expression of stem-associated ALDH2, SOX2, and Nanog markers than untreated cells. The proliferation of nuclear antigens in cells and the synthesis of RNA in microcells indicate cell self-defense, promoting resistance to applied therapy. These findings improve our understanding of microcell behavior in melanoma, potentially informing future strategies to counteract drug resistance in cancer treatment.

30 September 2025 in Medicina
Verified
Journal Article
Open access
PDF file
Valters VegelisValters Vegelis
Valters Vegelis
IMIeva Anna Miezaja
Ieva Anna Miezaja
IMIndra Mikelsone
Indra Mikelsone
AJAntra Jurka
Antra Jurka
Background and Objectives: Acute exercise lowers vagal HRV, yet it is unclear who will show the largest drop and whether simple questionnaires can identify them. To test whether resting HRV complexity (Sample Entropy) predicts the magnitude of acute vagal withdrawal and whether this physiology-based marker has greater practical utility than self-report activity/sleep measures for screening and recovery decisions. Materials and Methods: In a single-arm pre–post experimental study, twenty-nine students (20.4 ± 0.5 y; 13 males, 16 females) completed one morning visit (08:00–12:00 h). After a 2 min resting ECG and a Sustained Attention to Response Task (SART), participants cycled 15 min at 0.85 × (220 − age) bpm following a 5 min 25 W warm-up. HRV was re-recorded within ~2 min and SART ~5 min post exercise. The IPAQ defined low/medium/high activity tertiles. Correlations related baseline measures to change scores. Results: RMSSD decreased by −12.93 ms [−25.71, −2.03] (p = 0.003, r = 0.60) and SDNN by −14.91 ms [−22.30, 7.66] (p = 0.011, r = 0.51). Reaction time shortened slightly (−8.77 ms [−59.33, 30.40], p = 0.35). Activity tertiles did not differ in ΔRMSSD, ΔSDNN, or ΔRT (all p > 0.10). Sample Entropy predicted autonomic change (ΔRMSSD r = 0.43, p = 0.034; ΔSDNN r = 0.59, p = 0.002), whereas the PSQI and IPAQ did not. Equivalence tests showed non-significant tertile differences were not within our predefined equivalence bounds. Conclusions: Individuals with more complex resting HRV were more likely to show a larger immediate vagal withdrawal after moderate cycling. Questionnaires did not identify these responders. Non-linear HRV may aid practical screening/monitoring, whereas self-reports alone appear insufficient. Generalizability is limited by the homogeneous young adult sample.

17 August 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
VBVanda Bondare-Ansberga
Vanda Bondare-Ansberga
Peteris TretjakovsPeteris Tretjakovs
Peteris Tretjakovs
SSSimons Svirskis
Simons Svirskis
AJAntra Jurka
Antra Jurka
IMIndra Mikelsone
Indra Mikelsone
IHIlona Hartmane
Ilona Hartmane
Background/Objectives: Psoriasis is a systemic immune-mediated inflammatory disease associated with endothelial dysfunction and cardiovascular risk. This study evaluated relationships among clinical severity, cytokine activity, systemic vascular resistance, and skin microvascular reactivity in chronic plaque psoriasis before and after therapy. Methods: In this prospective longitudinal study, 34 patients with chronic plaque psoriasis and 19 matched controls were assessed. Patients were examined at baseline and after 12 months of clinically indicated systemic therapy. Psoriasis Area and Severity Index (PASI), serum IL-17A, IL-22, TNF-α, IL-12(p40), IL-10, VEGF-A, total peripheral resistance, and laser Doppler flowmetry post-occlusive reactive hyperemia indices were analysed. Results: PASI decreased markedly after therapy, from 20.6 ± 7.7 to 4.1 ± 5.3, with excellent discrimination between pre- and post-treatment states. IL-17A, IL-22, and IL-12(p40) decreased significantly, while TNF-α remained associated with disease severity. Total peripheral resistance and delayed psoriatic-skin hyperemia persisted and correlated with inflammatory/angiogenic markers, particularly IL-12(p40) and VEGF-A. Conclusions: Long-term therapy improves clinical and cytokine profiles in psoriasis, but vascular dysfunction may persist despite cutaneous improvement. Integrated cytokine–vascular assessment may complement PASI for evaluating systemic inflammatory burden and cardiovascular risk.